| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Gestone | Ferring Pharmaceuticals | Radiance Pharmaceuticals Limited | 50mg | 10ml | Injection | per vial | KES 1,902.00 |
| Gestone | Ferring Pharmaceuticals | Radiance Pharmaceuticals Limited | 100mg | 20ml | Injection | per vial | KES 3,300.00 |
| Susten | Sunlight International Trading (Africa) Co., Ltd | Harley's Limited | 100mg | 5 | Injection | per vial | KES 2,700.00 |
| Susten | Sunlight International Trading (Africa) Co., Ltd | Harley's Limited | 200mg | 5 | Injection | per vial | KES 4,840,.00 |
| Susten | Sunlight International Trading (Africa) Co., Ltd | Harley's Limited | 200mg | 30 | Capsule | per capsule | KES 2,220.00 |
| Susten | Sunlight International Trading (Africa) Co., Ltd | Harley's Limited | 400mg | 30 | Capsule | per capsule | KES 3,300.00 |
| Progesterone More info | |
|---|---|
| Mode Of Action | Progesterone or its derivatives |
| Drug Indication | Assisted reproductive technologies, corpus luteum insufficiency. |
| Precautions | Asthma; hepatic / renal / cardio-vascular impairment; history of mental depression; diabetes mellitus. |
| Contra-Indications | Thrombo-embolic disorders; undiagnosed vaginal bleeding. |
| Side Effects | Hypersensitivity reactions; changes in libido; acne; GI disturbances; weight gain; breakthrough bleeding; breast changes; mental depression; and fluid retention. |
| Dosage | Oral Progestogen component of HRT Adult: 200 mg OD at night for 12-14 days of each month Oral Amenorrhoea Adult: 400 mg OD for 10 days. Oral _Dysfunctional uterine bleeding Adult: 400 mg OD for 10 days. IM Dysfunctional uterine bleeding Adult: 5-10 mg OD for 5-10 days until 2 days prior to expected onset of menstruation. IM Amenorrhoea Adult: 5-10 mg OD for 5-10 days until 2 days prior to expected onset of menstruation Recurrent miscarriage with progesterone deficiency Adult: 25-100 mg two times per week from the 15th day of pregnancy until 8-16 wk. Intrauterine Contraception Adult: Insert the device [38 mg of progesterone] into the uterine cavity Vaginal Dysfunctional uterine bleeding Adult: 45 mg every other day from the 15th-25th day of the cycle. May increase dose to 90 mg in non-responders Vaginal Amenorrhoea Adult: 45 mg every other day from the 15th-25th day of the cycle. May increase dose to 90 mg in non-responders Vaginal Premenstrual syndrome Adult: 200 mg daily [max. 400 mg BD]. Treatment is usually started on days 12-14 of the cycle and continues until onset of menstruation. |
| Pregnancy Category | Category B: |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Categorized further into: |
| Drug Category | ENDOCRINE DRUGS |
| Drug Sub-Category | Steroid hormones and related synthetic drugs |